
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
CRF Health, a provider of patient-centered eSource technology solutions for the life sciences industry, announced that its TrialMax Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study.
Read the full release






